Expert Opinion on Therapeutic Targets

Ubiquitin ligases as therapeutic targets in HIV-1 infection
pp. 131-143(13)
Authors: Votteler, Jörg; Schubert, Ulrich

Targeting neutrophil elastase in cystic fibrosis
pp. 145-157(13)
Authors: Kelly, Emer; Greene, Catherine M; McElvaney, Noel G

Tissue-type plasminogen activator as a therapeutic target in stroke
pp. 159-170(12)
Authors: Gravanis, Iordanis; Tsirka, Stella E

Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs
pp. 171-183(13)
Authors: Malemud, Charles J; Miller, Andrew H

Therapeutic potential of CB2 targeting in multiple sclerosis
pp. 185-195(11)
Authors: Docagne, Fabian; Mestre, Leyre; Loría, Frida; Hernangómez, Miriam; Correa, Fernando; Guaza, Carmen

Molecularly targeted therapies in adult soft tissue sarcomas: present approach and future directions
pp. 197-207(11)
Authors: Aranha, Olivia; Agulnik, Mark

Mammalian target of rapamycin as a therapeutic target in oncology
pp. 209-222(14)
Authors: Abraham, Robert T; Eng, Christina H

Class IA phosphatidylinositol 3-kinase: from their biologic implication in human cancers to drug discovery
pp. 223-238(16)
Authors: Maira, Sauveur-Michel; Voliva, Charles; Garcia-Echeverria, Carlos

Bone disease drug discovery: examining the interactions between osteoblast and osteoclast
pp. 239-251(13)
Author: Sun, Sengen